2002
DOI: 10.1007/s11910-002-0078-2
|View full text |Cite
|
Sign up to set email alerts
|

Primitive neuroectodermal tumors/medulloblastoma

Abstract: The therapy for medulloblastoma/primitive neuroectodermal tumors of the central nervous system is surgery, followed by combination chemo-radiotherapy. The radiation field is the entire craniospinal axis, which is only avoided when treating infants. The treatment is, therefore, lengthy and toxic. Less aggressive therapy is given to patients who clinically appear to have less evidence of disease. Intensive basic research has begun to identify genetic factors of the disease, but these remain far from clinical app… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…Among these tumors, the highly metastatic medulloblastomas represent approximately 25% of all pediatric intracranial neoplasms [Saran, 2002]. These neoplasms arise from the cerebellum and mainly affect children between ages 5 and 15 [Weil, 2002]. Medulloblastomas are currently treated by surgical intervention, generally combined with aggressive chemotherapy [Kaaijk et al, 2003; Mazzola and Pollack, 2003].…”
mentioning
confidence: 99%
“…Among these tumors, the highly metastatic medulloblastomas represent approximately 25% of all pediatric intracranial neoplasms [Saran, 2002]. These neoplasms arise from the cerebellum and mainly affect children between ages 5 and 15 [Weil, 2002]. Medulloblastomas are currently treated by surgical intervention, generally combined with aggressive chemotherapy [Kaaijk et al, 2003; Mazzola and Pollack, 2003].…”
mentioning
confidence: 99%